Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial intermediate peptidase pseudogene 2 (abbreviated as MIPEPP2) is a pseudogene, which means it is a DNA sequence similar to a functional gene but is non-functional and does not encode an active protein. The closely related functional gene is “mitochondrial intermediate peptidase” (MIPEP), a real mitochondrial enzyme involved in protein maturation within mitochondria[2]. Pseudogenes like MIPEPP2 are typically not considered valid therapeutic targets, as they do not produce functional proteins, are not involved in active biological processes, and have no known disease associations or relevance for drug targeting. MIPEPP2 is likely included in gene databases for annotation and reference purposes, but it is not a therapeutic target. - The presence of “pseudogene” in the name indicates it is a non-functional gene. - MIPEP (without "pseudogene 2") is a real mitochondrial enzyme and should not be confused with MIPEPP2. - No drug interactions, disease roles, or biomarker references are reported for MIPEPP2 in major scientific, medical, or protein/gene repositories[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial intermediate peptidase pseudogene 2 (MIPEPP2).